| Date Initiated by Firm | June 03, 2019 |
| Create Date | July 16, 2019 |
| Recall Status1 |
Terminated 3 on August 28, 2020 |
| Recall Number | Z-1979-2019 |
| Recall Event ID |
83095 |
| 510(K)Number | K040435 |
| Product Classification |
Iga, antigen, antiserum, control - Product Code CZP
|
| Product | The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically. |
| Code Information |
Lot 368756 |
| FEI Number |
1823260
|
Recalling Firm/ Manufacturer |
Roche Diagnostics Corporation
9115 Hague Rd
Indianapolis
IN
46256-1025
|
| For Additional Information Contact | Roche Support Network Customer Support Center 800-428-2336 |
Manufacturer Reason for Recall | Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent. |
FDA Determined Cause 2 | Material/Component Contamination |
| Action | Urgent Medical Device Correction notification letters dated 6/3/19 were sent to customers. |
| Quantity in Commerce | 8 units |
| Distribution | The products were distributed to the following US states: AL, IN, and KY. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|
| 510(K) Database | 510(K)s with Product Code = CZP
|